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The potent, persistent immunity needed to prevent HIV
infection might be best achieved by priming cellular
immunity with replicating vectors and boosting antibod-
ies with optimally designed envelopes. Replicating Ad
vaccines infect epithelial cells on mucosal surfaces and
thus also elicit mucosal immunity. In chimpanzees, com-
pared to non-replicating Ad vaccines, at the same or lower
dose replicating Ad vaccines were better at eliciting cellu-
lar immunity and priming antibody responses. Mis-
matched envelope boosts induced broad neutralizing
activity to diverse R5 viruses and cross-clade ADCC activ-
ity. Multigenic Ad-SIV vaccines and SIV envelope subunit
boosts elicited strong protection in 39% of rhesus
macaques challenged mucosally with SIVmac251. Durabil-
ity of protection against a second challenge was estab-
lished in 73% of previously protected animals, associated
with persistent cellular immunity. Induction of memory
cells and broad, strong functional antibodies illustrates
the promise of this prime-boost vaccine strategy.
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